UBS remains bullish on Merck, reiterating its Buy rating with a $105 price target. This optimism follows Merck's planned $10 ...

Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 ...

Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data ...

Merck has officially embraced Veeva Systems' Vault CRM, sending positive ripples across Wall Street. The move, hailed as a ...

Cancer drug Keytruda maker Merck buys Verona before patent cliff Merck’s blockbuster drug Keytruda to lose key patent protections in 2028 ...

Veeva Systems (VEEV) announced on Wednesday that Merck (MRK), a major pharmaceutical company, has committed to its Vault CRM.

Veeva Systems (VEEV) recently experienced a 31% increase in share price over the last quarter, a period marked by significant developments for the company. Key to this movement was Merck's commitment ...

This software stock is nearing the buy point of a newly formed flat base. Here's how Merck is expanding its long-term partnership with Veeva Systems.

We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,” said Dave Williams, executive vice ...

Deep application provides foundation for commercial execution PLEASANTON, Calif., July 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known ...

Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ...